Evidence map›Paper›PMID 21724843›Full record

ArticleThe Journal of biological chemistry2011

Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.

François Béliveau, Cédric Brulé, Antoine Désilets, Brandon Zimmerman, Stéphane A Laporte, Christine L Lavoie, Richard Leduc

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Low intracellular iron increases the stability of matriptase-2.The Journal of biological chemistry · 2015
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

François BéliveauDepartment of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
Cédric BruléDepartment of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
Antoine DésiletsDepartment of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
Brandon ZimmermanDepartments of Medicine and Pharmacology & Therapeutics, McGill University Health Center Research Institute, McGill University, Montreal H3A 1A1, Canada.
Stéphane A LaporteDepartments of Medicine and Pharmacology & Therapeutics, McGill University Health Center Research Institute, McGill University, Montreal H3A 1A1, Canada.
Christine L LavoieDepartment of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
Richard LeducDepartment of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada. Electronic address: richard.leduc@usherbrooke.ca.
Université de Sherbrooke · CAMcGill University · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The type II transmembrane serine protease TMPRSS6 (also known as matriptase-2) controls iron homeostasis through its negative regulation of expression of hepcidin, a key hormone involved in iron metabolism. Upstream of the hepcidin-regulated signaling pathway, TMPRSS6 cleaves its target substrate hemojuvelin (HJV) at the plasma membrane, but the dynamics of the cell-surface expression of the protease have not been addressed. Here, we report that TMPRSS6 undergoes constitutive internalization in transfected HEK293 cells and in two human hepatic cell lines, HepG2 and primary hepatocytes, both of which express TMPRSS6 endogenously. Cell surface-labeled TMPRSS6 was internalized and was detected in clathrin- and AP-2-positive vesicles via a dynamin-dependent pathway. The endocytosed TMPRSS6 next transited in early endosomes and then to lysosomes. Internalization of TMPRSS6 is dependent on specific residues within its N-terminal cytoplasmic domain, as site-directed mutagenesis of these residues abrogated internalization and maintained the enzyme at the cell surface. Cells coexpressing these mutants and HJV produced significantly decreased levels of hepcidin compared with wild-type TMPRSS6 due to the sustained cleavage of HJV at the cell surface by TMPRSS6 mutants. Our results underscore for the first time the importance of TMPRSS6 trafficking at the plasma membrane in the regulation of hepcidin expression, an event that is essential for iron homeostasis.

Indexed as

Antimicrobial Cationic PeptidesCell MembraneClathrin-Coated VesiclesEndocytosisGene Expression RegulationGPI-Linked ProteinsHEK293 CellsHemochromatosis ProteinHepcidinsHep G2 CellsHomeostasisHumansIronMembrane ProteinsProtein TransportSerine EndopeptidasesAntimicrobial Cationic PeptidesGPI-Linked ProteinsHAMP protein, humanHemochromatosis ProteinHepcidinsHJV protein, humanIronMembrane ProteinsSerine EndopeptidasesTMPRSS6 protein, human

Identifiers

PMID21724843
PMCPMC3190711
OpenAlexW1992858904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.